Study of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203)

Study of Anlotinib in Patients With Medullary Thyroid Carcinoma(ALTER01031)

NCT02586350 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Prospective, Single-arm, Multicenter Exploratory Clinical Study of Anlotinib Combined With Bempegaldesleukin and Conventional Chemoradiotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Soft Tissue Sarcoma.

NCT07156643 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study of LVGN6051 Combined With Anlotinib in Patient With Soft Tissue Sarcoma

NCT05301764 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma

NCT06506838 ·Status: RECRUITING ·Phase: PHASE4

Efficacy and Safety of Cadonilimab Plus Anlotinib in Advanced STS That Failed the Previous First-line Standard Treatment

NCT05926700 ·Status: RECRUITING ·Phase: PHASE2

Anlotinib in Advanced Solid Tumors With FGFR Alteration

NCT03929965 ·Status: UNKNOWN ·Phase: NA

A Study of Anlotinib Combined With AK105 Injection in Subjects With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Advanced Solid Tumor

NCT04291248 ·Status: UNKNOWN ·Phase: PHASE2

Study of Anlotinib in Patients With Primary Malignant Bone Tumors

NCT03527888 ·Status: UNKNOWN ·Phase: PHASE2

A Multicenter, Single-arm, Prospective Phase II Clinical Study of Epalrotokewali Combined With Eribulin, Anlotinib, and Radiotherapy for the Treatment of Patients With Advanced Soft Tissue Sarcoma.

NCT07205185 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma

NCT03946943 ·Status: UNKNOWN ·Phase: PHASE2

Endostar Combined With Chemotherapy for Stage Ⅳ Soft Tissue Sarcoma

NCT03121833 ·Status: COMPLETED ·Phase: PHASE2

Anlotinib Plus Penpulimab in Advanced Non-Small-Cell Lung Cancer Previously Treated With PD-1/PD-L1 Inhibitors

NCT05460481 ·Status: UNKNOWN ·Phase: PHASE2

An Open-label, Single-arm Clinical Study of Stapokibart Injection in Combination with Tislelizumab Injection in Patients with Non-Small Cell Lung Cancer

NCT06883552 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma

NCT05807880 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter Trial

NCT03104335 ·Status: WITHDRAWN ·Phase: PHASE2

A Phase II Study of Apatinib in STS Patients

NCT03064243 ·Status: UNKNOWN ·Phase: PHASE2

A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

NCT05170958 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Phase II Study of Anlotinib and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Lung Cancer.

NCT07307443 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Anrotinib Hydrochloride Combined With Adriamycin for Neoadjuvant Treatment of High-grade Soft Tissue Sarcoma

NCT05747521 ·Status: UNKNOWN ·Phase: NA

Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma

NCT06384248 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Cadonilimab in the Treatment of Advanced Soft Tissue Sarcoma

NCT05656144 ·Status: UNKNOWN ·Phase: PHASE2

The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma

NCT04356872 ·Status: UNKNOWN ·Phase: PHASE2

A Phase I Clinical Trial to Evaluate LIT-00814 Tablets in Patients With Advanced Solid Tumor

NCT06205082 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1

Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy

NCT03121846 ·Status: UNKNOWN ·Phase: PHASE2

Pegylated Liposomal Doxorubicin Combined With Anlotinib for Neoadjuvant Treatment of Soft Tissue Sarcoma

NCT04765228 ·Status: UNKNOWN ·Phase: PHASE2